Clinical Trials Directory

Trials / Completed

CompletedNCT02979002

Accuracy of a Rapid Diagnostic Test for Cutaneous Leishmaniasis in Morocco

Status
Completed
Phase
Study type
Observational
Enrollment
219 (actual)
Sponsor
National School of Public Health, Morocco · Academic / Other
Sex
All
Age
5 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to estimate the accuracy of CL Detect Rapid Test™ compared to a composite reference standard test (Direct examination of skin smears + PCR test) in patients with clinically suspected Cutaneous Leishmaniasis disease in Morocco.

Detailed description

Study participants are recruited in nine health centers located in fourthree CL endemic provinces. The RDT under evaluation (index test) is the CL Detect™ Rapid Test (InBios, USA); a membrane-based amastigote antigen (peroxidoxin) detection test. The reference standard consists of two tests: direct examination of skin smears and PCR. For each patient, the health professional takes one dental broach sample and four skin smear samples from a single lesion. The dental broach sample is used for the RDT, which is done once. The skin smear samples are sent to provincial laboratories for microscopy testing and to reference laboratories in Morocco and Belgium for PCR testing by ITS1 PCR, Hsp70 genotyping and parasite load determination. Readers of index and reference tests do not have access to clinical information or any other test results. The results of the test under evaluation (RDT) and the molecular tests (PCR) are not communicated to the patient or her/his physician, as case management has to follow current clinical guidelines.

Conditions

Timeline

Start date
2016-12-01
Primary completion
2017-08-01
Completion
2017-08-01
First posted
2016-12-01
Last updated
2017-08-08

Locations

9 sites across 1 country: Morocco

Source: ClinicalTrials.gov record NCT02979002. Inclusion in this directory is not an endorsement.